Sivia Capital Partners’s Gossamer Bio GOSS Stock Holding History

Sivia Capital Partners’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1K	Buy	152,298 +60,619	+66%	+$16.9K	﹤0.01%	539
2026 Q1	$30.1K	Buy	91,679 +56,637	+162%	+$89K	0.01%	453
2025 Q4	$109K	Buy	35,042 +3,900	+13%	+$11.1K	0.02%	542
2025 Q3	$81.9K	Buy	31,142 +1,124	+4%	+$2.48K	0.02%	463
2025 Q2	$36.9K	Hold	30,018	–	–	0.01%	432
2025 Q1	$33K	Buy	30,018 +2,000	+7%	+$2.31K	0.02%	291
2024 Q4	$25.3K	Sell	28,018 -11,000	-28%	-$9.43K	0.01%	204
2024 Q3	$38.5K	Buy	39,018 +4,000	+11%	+$3.85K	0.02%	214
2024 Q2	$31.5K	Buy	35,018 +10,450	+43%	+$7.82K	0.02%	194
2024 Q1	$29K	Buy	+24,568	New	+$27K	0.02%	189

Other funds holding GOSS

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Waddell & Associates Memphis, Tennessee $2.02B AUM 36.49% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

CWMA

Capstone Wealth Management (Alabama) Tuscaloosa, Alabama $216M AUM 32.76% 1-Year Est. Return

Sivia Capital Partners's GOSS Position: Q2 2026 in Review

Sivia Capital Partners increased its Gossamer Bio (GOSS) stake by 66% in Q2 2026, buying an estimated $16.9K and bringing the position to 152,298 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Sivia Capital Partners first reported a position in GOSS in Q1 2024 and has held it in 10 quarters since. The position peaked at $109K in Q4 2025. 23 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Sivia Capital Partners held 152,298 shares of Gossamer Bio worth $25.1K as of Q2 2026.
Sivia Capital Partners bought 60,619 Gossamer Bio shares in Q2 2026, an estimated $16.9K.
Gossamer Bio made up ﹤0.01% of Sivia Capital Partners's portfolio in Q2 2026, its #539 holding.
Sivia Capital Partners first reported a position in Gossamer Bio in Q1 2024 and has held it in 10 quarters since.
Sivia Capital Partners's Gossamer Bio position peaked at $109K in Q4 2025.
23 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.